Therapeutic options in COVID-19

Keyphrases

• Therapeutic Potential 100%
• COVID-19 100%
• Prophylactic Treatment 100%
• Monoclonal Antibody 66%
• Early Treatment 66%
• Passive Immunization 66%
• Staged Treatment 66%
• Inflammatory Diseases 33%
• Severe Disease 33%
• Risk Factors 33%
• Hospitalized Patients 33%
• Potential Treatments 33%
• Corticosteroids 33%
• Antiviral Agents 33%
• Interleukin-6 33%
• Anticoagulation 33%
• Moderate to Severe 33%
• Cytokine Storm 33%
• Pulmonary Vasodilators 33%
• High-risk Population 33%
• Critical Patient 33%
• Protonation 33%
• Rescue Procedure 33%
• Neuromuscular Blockade 33%
• Contracting COVID-19 33%
• Adult Respiratory Distress Syndrome 33%
• JAK Inhibitors 33%
• Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) 33%
• Lung Involvement 33%
• Oxygen Support 33%
• Refractory Hypoxemia 33%
• Severe Patients 33%
• Alveolar Recruitment 33%

Medicine and Dentistry

• Prophylaxis 100%
• COVID-19 100%
• Monoclonal Antibody 66%
• Passive Immunization 66%
• Disease 33%
• Antivirus Agent 33%
• Inflammatory Disorder 33%
• Anticoagulation 33%
• Peripheral Vasodilating Agent 33%
• High Risk Population 33%
• Hypoxemia 33%
• Cytokine Storm 33%
• Extracorporeal Membrane Oxygenation 33%
• Neuromuscular Blocking 33%
• Janus Kinase Inhibitor 33%
• Acute Respiratory Distress Syndrome 33%
• Lung 33%